The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics.

Venture Capital

The Column Group

The Column Group's headquarters in San Francisco, CA, United States

Partners

The Column Group's leadership team has a wealth of experience in the biotech industry. The Senior VP used to work at Amgen, the CEO used to work at Tularik, and the Director of Molecular Biology used to work at Genentech. The team also has experience working in academia, with the President and Chief Scientific Officer having previously worked as a lecturer at UC Berkeley.

��

People (5)

Jobs (0)

Other teams

Leadership Team

Science Partners

Venture Partners

��������